Urovant Sciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch UROV and buy or sell other stocks, options, and ETFs commission-free!

About UROV

Urovant Sciences Ltd. is a clinical-stage biopharmaceutical company, which through its subsidiaries, engages in the development and commercialization of therapies for urologic conditions. Its pipeline includes Vibegron (RVT-901) and URO-902. 

CEO
James A. Robinson, Jr.
CEOJames A. Robinson, Jr.
Employees
Employees
Headquarters
London, Greater London
HeadquartersLondon, Greater London
Founded
2017
Founded2017
Employees
Employees

UROV Key Statistics

Market cap
531.75M
Market cap531.75M
Price-Earnings ratio
-3.09
Price-Earnings ratio-3.09
Dividend yield
Dividend yield
Average volume
222.74K
Average volume222.74K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$16.26
52 Week high$16.26
52 Week low
$7.15
52 Week low$7.15
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.